All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.

Our financial data in facts & figures

OUR REVENUES

EBITDA (2021)

75,5 (20,4% of turnover)

EBIT (2021)

53,8 (14,5% of turnover)

NET RESULT (2021)

36,4 (9,8% of turnover)

Related Documents

Consolidated Financial Statements Fidia Farmaceutici Group as at 31 December 2021

OUR FIGURES BY FOCUS AREA (€ Millions, 2021)

Net revenue

371,2

€ Millions

145,7 € Millions

JOINT CARE

43,5 € Millions

SKIN CARE

72,0 € Millions

EYE CARE

4,5 € Millions

ACTIVE SUBSTANCES

28,6 € Millions

CORTICOSTEROIDS

76,9 € Millions

OTHER

OUR FIGURES BY PRODUCT CATEGORY (€ millions, 2021)

PRESCRIPTION DRUGS: 33%*
MEDICAL DEVICES: 43%*
VACCINES: 5%*
OTHER: 19%*

_{*percentage referring to Fidia Farmaceutici S.p.A.}

OUR FIGURES BY GEOGRAPHICAL AREA (€ millions, 2021)

Net revenue

371,2

€ Millions

190,1 € Millions

ITALY

88,8 € Millions

EUROPE

13,3 € Millions

MENA

53,6 € Millions

USA

25,5 € Millions

RoW

OUR GROUP

GOVERNANCE

Find out more

Our financial data in facts & figures

PRESCRIPTION DRUGS: 33%* MEDICAL DEVICES: 43%* VACCINES: 5%* OTHER: 19%*

PRESCRIPTION DRUGS: 33%*
MEDICAL DEVICES: 43%*
VACCINES: 5%*
OTHER: 19%*